Boston Beer Coの空売り状況は、投資家がBoston Beer Coの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Boston Beer Co (NYSE:SAM) 株価情報, 空売り情報

Boston Beer Co

Boston Beer is a top player in high-end malt beverages and adjacent categories in the us, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates over 95% of sales in the us.

Boston Beer Company, Inc. (The) Common Stock

Boston Beer Co Inc

Silvercrest Asset Management Group Inc. - Common Stock

Silvercrest Asset Management Group Inc

SANDVIK MATLS TECH HLDG by SANDVIK MATLS TECHNOLOGY HLDG AB

Alleima AB

SAMSARA LUGGAGE INC by Samsara Luggage, Inc.

Samsara Luggage Inc

The Advisors' Inner Circle Fund III Strategas Macro Momentum ETF

Sama Resources Inc

Samoyedcoin - United States dollar

The Advisors' Inner Circle Fund III Strategas Macro Thematic Opportunities ETF

Shares of major alcohol producers and distributors declined sharply Friday following a warning issued by U.S. Surgeon General Vivek Murthy about the increased cancer risks <a href="https://www.benzinga.com/government/regulations/25/01/42787400/alcohol-increases-cancer-risk-surgeon-general-warns">associated with alcohol consumption.</a>
What To Know: Murthy&#8217;s advisory emphasized the need for updated health warning labels to reflect mounting evidence of alcohol&#8217;s connection to cancer. These labels have not been revised since 1988. The advisory also called for reassessing recommended alcohol consumption limits, highlighting alcohol's role as the third-leading preventable cause of cancer in the United States, behind tobacco and obesity.
Murthy&#8217;s statement drew attention to alcohol&#8217;s association with at least seven types of cancer, including breast, liver and colorectal cancers. He pointed out that alcohol consumption contributes to approximately 100,000 cancer cases and 20,000 deaths annually in the United States. The announcement highlighted that only 45% of American adults are aware of the cancer risks posed by alcohol.
Stocks of leading alcohol companies reacted negatively to the news. 
Molson Coors Beverage Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) saw its shares drop by 3.72%, while Boston Beer Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) shares fell 4.26%. Anheuser-Busch InBev Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>)&#8217;s stock declined by 1.84% and Constellation Brands Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) saw a 1.5% decrease. Diageo Inc.&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) stock also traded lower, falling 3.15%. Brown-Forman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>), the maker of Jack Daniel&#8217;s whiskey, experienced a 2.58% decline.
The Surgeon General's advisory reignited discussions about public health measures and the potential for new regulations requiring updated warning labels on alcohol products. 
Price Action: Molson Coors shares were down 3.25% at $55.27, Boston Beer shares were down 3% at $292.60 and Anheuser-Busch shares were down 1.85% at $49 at the time of writing, according to <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072924&amp;t=be2bearmibe3na1">Benzinga Pro.</a>
Image Via Shutterstock.

News

Movers

Alcohol Stocks Are Falling Today: What's Going On?

WIIM

Fomento Economico Mexicano S.A.B. De C.V.

Shares of alcohol stocks are trading lower after US Surgeon General Murthy issued an advisory warning alcohol consumption could raise cancer risk.

Surgeon General Vivek H. Murthy issued an advisory Friday warning about the cancer risks associated with alcohol consumption and calling for updates to health warning labels that haven't been revised since 1988. Murthy also stressed the need to reassess recommended alcohol limits, citing mounting evidence of its role in <a href="https://www.benzinga.com/general/health-care">cancer development</a>. The advisory sent alcohol stocks plunging across the board in Friday morning trading.
"Higher alcohol consumption increases alcohol-related cancer risk, yet only 45% of American adults are aware that consuming alcohol increases their risk of developing cancer," Murthy&nbsp;wrote on X.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">NEW: Today, I'm releasing a Surgeon General's Advisory on the causal link between alcohol consumption and increased cancer risk. Alcohol is the 3rd leading preventable cause of cancer in the U.S., contributing to about 100,000 cancer cases and 20,000 cancer deaths each year. <a href="https://t.co/sKTlPAZlFw">pic.twitter.com/sKTlPAZlFw</a>
&mdash; Dr. Vivek Murthy, U.S. Surgeon General (@Surgeon_General) <a href="https://twitter.com/Surgeon_General/status/1875150669935685855?ref_src=twsrc%5Etfw">January 3, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
"Alcohol is a well-established, preventable cause of cancer responsible for about 100,000 cases and 20,000 deaths annually in the United States," Murthy stated. He added that alcohol consumption ranks as the third-leading preventable cause of cancer in the U.S., trailing only tobacco and obesity. 
Murthy's advisory, <a href="https://www.washingtonpost.com/health/2025/01/03/alcohol-cancer-warning-surgeon-general/">noted</a> the Washington Post, pointed to a direct association between alcohol consumption and at least seven types of cancer, including breast, liver and colorectal cancers. The Post pointed out that 16.4% of annual breast cancer cases are attributed to alcohol and that any mandatory changes to the health warning labels would need to be approved by the new Congress coming in under President-elect Donald Trump.
<h2 class="wp-block-heading">Alcohol Makers, Distributor Stocks React</h2>
Stocks of major alcohol companies fell sharply following the announcement, according to Benzinga Pro. 
Brown-Forman Corp. (NYSE: <a href="https://www.benzinga.com/quote/BF-B">BF-B</a>) producer of Jack Daniel's whiskey, is down 2.58%. Constellation Brands Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>), distributor of Corona beers and Mondavi wines, declined by 1.5%. Anheuser-Busch InBev (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>) is down 1.84%, Molson Coors Beverage Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) is down by 3.37%% while the Boston Beer Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>), maker of Sam Adams, plunged 4.26%. Diageo plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>) is trading down 3.15%. 
Photo: <a href="https://www.thecrimson.com/writer/1219214/Courtesy%20of%20U.S.%20Department%20of%20Health%20and%20Human%20Services__/">Courtesy of U.S. Department of Health and Human Services</a>

Equities

Government

Regulations

Health Care

Markets

BF/B

Molson Coors, Diageo, Boston Beer Tumble As Surgeon General Warns 'Alcohol Consumption Increases' Cancer Risk

Guidance

Boston Beer Updates 2024 Guidance To Reflect The Impact Of A Negotiated Cash Payment Under An Amendment And Restatement Of An Existing Production Agreement With A Third-Party Supplier, Rauch North America Inc; Company Expects To Record Pre-Tax Contract Settlement Expense Of $26M Or $1.70 After Tax Per Diluted Share Impact In Q4 2024

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) in the last three months.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $340.5, a high estimate of $389.00, and a low estimate of $318.00. Experiencing a 1.8% decline, the current average is now lower than the previous average price target of $346.75. 
<img src="https://www.benzinga.com/files/images/story/2024/1733486466_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The analysis of recent analyst actions sheds light on the perception of Boston Beer Co by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$318.00</td>
<td>$318.00</td>
</tr>
<tr>
<td>Michael Lavery</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$330.00</td>
<td>$325.00</td>
</tr>
<tr>
<td>Kaumil Gajrawala</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$325.00</td>
<td>$355.00</td>
</tr>
<tr>
<td>Bill Kirk</td>
<td>Roth MKM</td>
<td>Maintains</td>
<td>Buy</td>
<td>$389.00</td>
<td>$389.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Boston Beer Co. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Boston Beer Co compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Boston Beer Co's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Boston Beer Co's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/SAM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Boston Beer Co analyst ratings.</a>
<h2>Discovering Boston Beer Co: A Closer Look</h2>
Boston Beer is a top player in high-end malt beverages and adjacent categories in the us, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates over 95% of sales in the us.
<h3>Boston Beer Co: Delving into Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Boston Beer Co's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 0.64%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Staples sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 5.54%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Boston Beer Co's ROE stands out, surpassing industry averages. With an impressive ROE of 3.26%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Boston Beer Co's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.38%, the company showcases efficient use of assets and strong financial health.
Debt Management: Boston Beer Co's debt-to-equity ratio is below the industry average. With a ratio of 0.04, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Expert Outlook: Boston Beer Co Through The Eyes Of 4 Analysts

Needham analyst Gerald Pascarelli initiates coverage on Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) with a Hold rating.

Initiation

Needham Initiates Coverage On Boston Beer Co with Hold Rating

Donald Trump&#8216;s 2024 presidential election win put several sectors in the spotlight, <a href="https://www.benzinga.com/topic/alcohol">including alcohol stocks.</a>
What Happened: Some people watched the outcome of <a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election">election night</a> on television from their home. Others likely scrolled along with social media on their phone. Some attended watch parties with friends and families, similar to a Super Bowl party or one for <a href="https://www.benzinga.com/top-stories/24/08/40610039/are-nvidia-earnings-wall-streets-super-bowl-super-bulls-arrange-watch-parties-in-new-york-city">Nvidia's quarterly earnings.</a> 
Regardless of who voters wanted to win — Trump or Kamala Harris — they may have bought more alcohol for Election Day this year, at least in New York, with liquor stores reporting a busy day.
One liquor store <a href="https://nypost.com/2024/11/06/us-news/nyc-liquor-stores-were-crazy-busy-on-election-night-workers-say-weve-been-spending-hours-just-restocking/">told </a>the New York Post they were three to four times busier than a regular weekday on Election Day with heavy sales coming in the early afternoon and around 5 p.m. ET. An employee from Brooklyn's Juice Box liquor store told the Post there was also a noticeable trend from many customers.
"People were buying sparkling wine and a bottle of liquor for both (outcomes)," the employee said.
Employees from other New York stores noticed the same trend. Customers were either buying one type of alcohol for a happy outcome or one for a negative outcome.
"I have no idea if people will be drowning their sorrows or celebrating," the Juice Box employee added.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent110724">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: While it is only one day of the year, Election Day 2024 could provide a short bump for alcohol stocks like Diageo Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>) and Constellation Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>). Beer stocks like Anheuser-Busch InBev (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>), Boston Beer Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) and Molson Coors Beverage Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) may have also benefitted from Election Day.
Alcohol may be a coping or celebratory item for Election Day in the U.S., but in India the country <a href="https://timesofindia.indiatimes.com/world/us/us-election-2024-does-america-have-dry-days-like-india-during-election-season/articleshow/114945854.cms">has </a>dry days of no alcohol around their elections with residents unable to drink for 48 hours before the vote, on election day or as the vote is being totaled.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/11/41817245/will-trump-be-sentenced-in-hush-money-trial-or-will-his-criminal-problems-go-away">Will Trump Be Sentenced In Hush Money Trial Or Will His &#8216;Criminal Problems Go Away&#8217;?</a></li>
</ul>
Image: Shutterstock

Politics

Trading Ideas

Alcohol Stocks To Get A Boost From 2024 Election? Busy Liquor Stores Say Voters 'Drowning Their Sorrows Or Celebrating'

Boston Beer Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) reported third-quarter results, with net revenue increasing 0.6% to $605.5 million and a gross margin of 46.3%, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/g41530242/boston-beer-reports-third-quarter-financial-results" rel="noreferrer noopener">rising 60 basis points year over year.</a>
Piper Sandler analyst Michael S. Lavery increased<a target="_blank" href="https://www.benzinga.com/quote/SAM/analyst-ratings" rel="noreferrer noopener"> the price forecast to $330 from $325, with an Overweight rating.</a>
The analyst sees potential growth from the national rollout of Hard Mtn Dew within its own distribution network, primarily in 2025.
While transition disruptions have been more significant than expected, Hard Mtn Dew sales did increase in the third quarter of 2024, the analyst adds.
Per Lavery, the company is well-positioned to maintain shelf space during the Spring 2025 resets, contrasting with a 4% decline in 2024.
This improvement has been aided by replacing some declining or rationalized Truly SKUs with new offerings, including Truly Unruly and Twisted Tea Extreme, both with an 8% ABV compared to the 5% ABV of the original line.
The analyst adds that new products, particularly those with higher alcohol by volume (ABV), are performing well.
Consumer interest has been shown in its limited distribution area, with estimates suggesting potential sales of $150 million to $300 million by 2025, although the analyst&#8217;s current projection is just under $100 million.
Lavery raised the 2024 EPS estimates from $8.50 to $9.40 and the FY25 EPS estimates from $11.75 to $12.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41551304/bkvs-integrated-operations-offer-value-analyst-highlights-unique-closed-loop-system" rel="noreferrer noopener">BKV&#8217;s Integrated Operations Offer Value, Analyst Highlights Unique &#8216;Closed-Loop&#8217; System And Growth Prospects</a>
RBC Capital Markets analyst Nik Modi reiterated the Sector Perform rating, with a price forecast of $318.
According to Modi, the firm is effectively &#8220;controlling the controllables,&#8221; which is supporting margin expansion even though volumes are down year-over-year.
As 2025 approaches, the analyst acknowledges ongoing challenges with volume growth but anticipates modest gains primarily from Twisted Tea. While Sun Cruiser is seen as promising, Truly is still viewed as a work in progress.
The analyst raised the FY25 adjusted EPS estimate from $11.00 to $11.21.
Price Action: SAM shares are trading higher by 0.25% to $302.62 at last check Friday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/41541240" target="_blank" rel="noreferrer noopener">US Stocks Set To Rise As Treasury Yields Ease, Tesla, Spirit Airlines Among Stocks In Focus: Fund Manager Says Despite Elon Musk&#8217;s Company&#8217; Firing On All Cylinders,&#8217; It&#8217;s Still Not A &#8216;Good Time To Buy&#8217;</a></li>
</ul>

Analyst Color

Price Target

Reiteration

General

Boston Beer's Strategic Moves With Hard Mtn Dew And Twisted Tea Position It For 2025 Gains, Analysts Say

RBC Capital analyst Nik Modi reiterates Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) with a Sector Perform and maintains $318 price target.

RBC Capital Reiterates Sector Perform on Boston Beer Co, Maintains $318 Price Target

Piper Sandler analyst Michael Lavery maintains Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) with a Overweight and raises the price target from $325 to $330.

Piper Sandler Maintains Overweight on Boston Beer Co, Raises Price Target to $330

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Scotiabank analyst Tanya Jakusconek downgraded Newmont Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) from Sector Outperform to Sector Perform and lowered the price target from $59 to $55. Newmont shares closed at $49.25 on Thursday. <a href="https://www.benzinga.com/quote/NEM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel analyst Matthew Smith downgraded the rating for The Kraft Heinz Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>) from Buy to Hold and slashed the price target from $40 to $38. Kraft Heinz shares closed at $35.03 on Thursday. <a href="https://www.benzinga.com/quote/KHC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Craig-Hallum analyst Jeremy Hamblin downgraded Boot Barn Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) from Buy to Hold but raised the price target from $154 to $162. Boot Barn shares closed at $160.78 on Thursday. <a href="https://www.benzinga.com/quote/BOOT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Kaumil Gajrawala downgraded the rating for The Boston Beer Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) from Buy to Hold and slashed the price target from $355 to $325. Boston Beer shares closed at $301.88 on Thursday. <a href="https://www.benzinga.com/quote/SAM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird analyst Peter Arment downgraded Honeywell International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) from Outperform to Neutral and cut the price target from $223 to $217. Honeywell shares closed at $209.10 on Thursday. <a href="https://www.benzinga.com/quote/HON/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying HON stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="523" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25093108/image-259-1024x523.png" alt="" class="wp-image-614479" style="width:681px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25093108/image-259-1024x523.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25093108/image-259-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25093108/image-259-768x392.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25093108/image-259.png 1247w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41528323/jim-cramer-says-hold-on-to-palantir-let-them-walk-it-up-warns-that-travere-therapeutics-is-losing-a">Jim Cramer Says &#8216;Hold On&#8217; To Palantir, &#8216;Let Them Walk It Up&#8217;; Warns That Travere Therapeutics Is Losing A &#8216;Ton Of Money&#8217;</a></li>
</ul>

Downgrades

BOOT

This Honeywell Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 0.3% on Friday.
Shares of Capri Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) fell sharply in today's pre-market trading following reports that a judge has blocked the company's<a href="https://www.benzinga.com/m-a/24/10/41533172/capri-holdings-stock-drops-by-half-after-judge-blocks-tapestry-merger"> pending merger with Tapestry.</a>
Following an eight-day trial in which the U.S. Federal Trade Commission argued that a merger between Capri and Tapestry would remove competition from the U.S. handbag space, a U.S. judge has moved to block the pending merger, according to Reuters.
Capri shares tumbled 47.1% to $22.01 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Coursera, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) shares dipped 19.2% to $6.16 in today's pre-market trading after the company issued fourth-quarter revenue guidance below estimates and cut its FY24 revenue guidance,</li>
<li>The Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) shares declined 15.4% to $46.51 following downbeat quarterly results.</li>
<li>Joby Aviation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JOBY#NYSE">JOBY</a>) dipped 8.1% to $5.55 in pre-market trading as the company announced the pricing of public offering of common stock.</li>
<li>Tevogen Bio Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVGN#NASDAQ">TVGN</a>) shares fell 7.8% to $2.36 in pre-market trading. Tevogen Bio recently announced its Artificial Intelligence effort, Tevogen AI, has joined Microsoft for Startups.</li>
<li>DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) shares fell 6.6% to $69.89 in pre-market trading following third-quarter results.</li>
<li>Sibanye Stillwater Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBSW#NYSE">SBSW</a>) declined 4.6% to $4.73 in pre-market trading after surging more than 12% on Thursday.</li>
<li>The Boston Beer Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) shares fell 4% to $289.80 in pre-market trading following third-quarter results.</li>
<li>Masimo Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASI#NASDAQ">MASI</a>) shares fell 4% to $135.23 in pre-market trading. Masimo will report third quarter financial results, after the closing bell on Tuesday, Nov. 5.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41528323/jim-cramer-says-hold-on-to-palantir-let-them-walk-it-up-warns-that-travere-therapeutics-is-losing-a">Jim Cramer Says &#8216;Hold On&#8217; To Palantir, &#8216;Let Them Walk It Up&#8217;; Warns That Travere Therapeutics Is Losing A &#8216;Ton Of Money&#8217;</a></li>
</ul>

Pre-Market Outlook

COUR

CPRI

DXCM

JOBY

MASI

SBSW

TBBK

TVGN

Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Jefferies analyst Kaumil Gajrawala downgrades Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) from Buy to Hold and lowers the price target from $355 to $325.

Jefferies Downgrades Boston Beer Co to Hold, Lowers Price Target to $325

r guidance. The Company's actual 2024 results could vary significantly from the current projection and are highly sensitive to changes in volume projections and supply chain performance as well as inflationary impacts.
<figure class="table"> 
<table>
<tbody>
<tr>
<td>Full Year 2024</td>
<td>Current Guidance</td>
<td>Prior Guidance</td>
</tr>
<tr>
<td>Depletions and Shipments Percentage Decrease</td>
<td>Down low single digits</td>
<td>Down low single digit to zero</td>
</tr>
<tr>
<td>Price Increases</td>
<td>2%</td>
<td>1% to 2%</td>
</tr>
<tr>
<td>Gross Margin</td>
<td>44% to 45%</td>
<td>43% to 45%</td>
</tr>
<tr>
<td>Advertising, Promotion, and Selling Expense Year Over Year Change ($ million)</td>
<td>($5) to $15</td>
<td>($5) to $15</td>
</tr>
<tr>
<td>Effective Tax Rate</td>
<td>30%</td>
<td>28.5%</td>
</tr>
<tr>
<td>GAAP EPS</td>
<td>$5.50 to $7.50</td>
<td>$7.00 to $11.00</td>
</tr>
<tr>
<td>Non-GAAP EPS</td>
<td>$8.00 to $10.00</td>
<td>- &nbsp;</td>
</tr>
<tr>
<td>Capital Spending ($ million)</td>
<td>$80 to $95</td>
<td>$90 to $110</td>
</tr>
</tbody>
</table>
</figure>
The non-GAAP earnings per share (Non-GAAP EPS) projection excludes the impact of the non-cash brand impairments of $42.6 million or $2.49 per diluted share.
Underlying the Company's current 2024 projections are the following full-year estimates and targets:
<ul>
<li>The advertising, selling and promotional expense projection does not include any changes in freight costs for the shipment of products to the Company's distributors.</li>
<li>During full year 2024, the Company estimates shortfall fees will negatively impact gross margin by 65 to 75 basis points and the non-cash expense of third-party production pre-payments will negatively impact gross margins by 95 to 105 basis points.</li>
<li>The Company's business is seasonal, with the first quarter and fourth quarter being lower volume quarters and the fourth quarter typically the lowest absolute gross margin rate of the year.</li>
<li>The increase in the estimated full year effective tax rate is due to the impact of the third quarter non-cash brand impairment charge which decreased estimated full year pre-tax income but did not significantly change estimated full year non-deductible expenses.</li>
</ul>
2025 Financial Guidance
The Company is planning to provide full year 2025 financial guidance during its fourth quarter earnings call in February 2025.

The Boston Beer Company Sees FY24 EPS $8.00-$10.00 Vs $9.60 Est.

Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) reported quarterly earnings of $5.35 per share which beat the analyst consensus estimate of $4.98 by 7.43 percent. This is a 14.81 percent increase over earnings of $4.66 per share from the same period last year. The company reported quarterly sales of $605.48 million which beat the analyst consensus estimate of $601.06 million by 0.73 percent. This is a 0.64 percent increase over sales of $601.60 million the same period last year.

Earnings

Earnings Beats

Boston Beer Co Q3 Adj $5.35 Beats $4.98 Estimate, Sales $605.48M Beat $601.06M Estimate

In the last three months, 4 analysts have published ratings on Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>), offering a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $355.25, a high estimate of $389.00, and a low estimate of $318.00. This current average has decreased by 2.67% from the previous average price target of $365.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1729706471_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of Boston Beer Co among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Bill Kirk</td>
<td>Roth MKM</td>
<td>Maintains</td>
<td>Buy</td>
<td>$389.00</td>
<td>$389.00</td>
</tr>
<tr>
<td>Bill Kirk</td>
<td>Roth MKM</td>
<td>Lowers</td>
<td>Buy</td>
<td>$389.00</td>
<td>$395.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$318.00</td>
<td>$332.00</td>
</tr>
<tr>
<td>Michael Lavery</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$325.00</td>
<td>$344.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Boston Beer Co. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Boston Beer Co compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Boston Beer Co's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Boston Beer Co's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/SAM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Boston Beer Co analyst ratings.</a>
<h2>Discovering Boston Beer Co: A Closer Look</h2>
Boston Beer is a top player in high-end malt beverages and adjacent categories in the us, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates over 95% of sales in the us.
<h3>Breaking Down Boston Beer Co's Financial Performance</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining Boston Beer Co's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -4.01% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Boston Beer Co's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.04% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Boston Beer Co's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 5.02%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Boston Beer Co's ROA excels beyond industry benchmarks, reaching 3.71%. This signifies efficient management of assets and strong financial health.
Debt Management: Boston Beer Co's debt-to-equity ratio is below the industry average. With a ratio of 0.04, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

4 Analysts Assess Boston Beer Co: What You Need To Know

Roth MKM analyst Bill Kirk reiterates Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) with a Buy and maintains $389 price target.

Roth MKM Reiterates Buy on Boston Beer Co, Maintains $389 Price Target

Buybacks

On Oct 2, Boston Beer Company Board Authorized Increase In Expenditure Limit For Co's Stock Repurchase Program By $400M

Green Thumb Industries Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/GTII#CSE">GTII</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTCQX">GTBIF</a>), the owner of RISE Dispensaries, announced a $50 million share repurchase program on Monday.
What Happened: The company's board of directors approved the repurchase of up to 10,573,860 of its subordinate voting shares from time to time over the next 12 months.
The program will commence on Sept. 23, 2024, and expire on Sept. 22, 2025. Green Thumb's previous repurchase program expired on Sept. 10, 2024, under which the company repurchased 6.5 million shares for $73.3 million.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/16080441/ccc-oct-24-banner__1_-21.gif" alt="" class="wp-image-549412" /></a></figure>
The news comes on the heels of the company's announcement that it has closed on a $150 million five-year syndicated credit facility led by Valley National Bank, <a href="https://www.benzinga.com/markets/cannabis/24/09/40834346/cannabis-giant-green-thumb-secures-150m-credit-facility-strengthens-our-already-clean-balance-sh">the principal subsidiary of Valley National Bancorp.</a>
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40175373/green-thumbs-q2-revenue-soars-11-to-280m-is-rising-cost-something-to-watch">Green Thumb's Q2 Revenue Soars 11% To $280M, Is Rising Cost Something To Watch?</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
Why It Matters: Green Thumb CEO Ben Kovler said the buyback program allows it to be more flexible in using its cash reserves to repurchase more shares, if an opportunity arises.
"We love our balance sheet, particularly in light of the recent refinancing, and remain open to strategic M&amp;A, capital expenditures into the business and unique investment opportunities," Kovler said. "The future is bright for Green Thumb as America craves more well-being and more cannabis."
In June, Green Thumb expressed interest in merging with Boston Beer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>), a deal observers thought could reshape the <a href="https://www.benzinga.com/topic/cannabis-beverages">cannabis and beverage sectors</a>. The transaction would create a company with $3 billion in proforma 2023 revenues, with two-thirds from Boston Beer.
<h3 class="wp-block-heading">GTBIF Price Action</h3>
Green Thumb's shares traded 0.04% higher at $10.33 per share after the market close on Friday afternoon.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40427128/verano-green-thumb-marimeds-strong-q2-unpacking-the-cannabis-earnings-surge">Verano, Green Thumb &amp; MariMed's Strong Q2: Unpacking The Cannabis Earnings Surge</a></li>
</ul>

Cannabis

Financing

CSE:GTII

GTBIF

GTII

Cannabis Giant Green Thumb Confirms $50M Share Repurchase Program, CEO Open To M&A And 'Unique Investments'

Green Thumb Industries Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/GTII#CSE">GTII</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTCQX">GTBIF</a>), the owner of RISE Dispensaries announced on Thursday it has closed on a $150 million 5-year syndicated credit facility led by Valley National Bank, the principal subsidiary of Valley National Bancorp.
What Happened: The notes have a maturity date of Sept. 11, 2029 and will bear interest from the date of issue at a secured overnight financing rate (SOFR) + 500 basis points, payable quarterly.
The company said the transaction did not involve the issuance of any Green Thumb equity to any of the participating banks.
Why It Matters: The Chicago-based cannabis consumer packaged goods company plans to use proceeds along with existing cash to retire its $225 million senior secured debt due April 30, 2025.
Ben Kovler, the company's founder, chairman and CEO called the financing deal "a first-of-its-kind credit facility for the U.S. cannabis industry."
"This new capital funding further strengthens our already clean balance sheet for another five years," he said.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/12092702/ccc-oct-24-banner__1_-18.gif" alt="" class="wp-image-544696" /></a></figure>
What's Next: "We plan to double down on our efforts to build brands that Americans love," Kovler continued. "Cannabis is a means toward more well-being, and we know Americans are craving well-being now more than ever. The future of America is more cannabis, and this debt arrangement allows us to invest in the future of America's well-being.&#8221;
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40175373/green-thumbs-q2-revenue-soars-11-to-280m-is-rising-cost-something-to-watch">Green Thumb&#8217;s Q2 Revenue Soars 11% To $280M, Is Rising Cost Something To Watch?</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">Rumors Of Green Thumb And Boston Beer Merger</h3>
In June Green Thumb made headlines for expressing interest in merging with Boston Beer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>), a move that has the potential to reshape the <a href="https://www.benzinga.com/topic/cannabis-beverages">cannabis and beverage sectors.</a>
A June 4th letter from Kovler to Boston Beer chairman Jim Koch expressed interest in a merger. The transaction would create a company with $3 billion in proforma 2023 revenues, with two-thirds from Boston Beer.
A report by Pablo Zuanic of Zuanic &amp; Associates explained at the time that Boston Beer's revenues are projected to increase by 2% in 2024, while Green Thumb&#8217;s are expected to grow by 15%. Despite higher sales, SAM operates in a flat to declining industry, whereas Green Thumb is in a growth sector, as highlighted in a summary of Zuanic's report by  Benzinga's <a href="https://www.benzinga.com/author/nicol-s-jose-rodriguez">Nicolás Jose Rodriguez.</a>
That said, Green Thumb&#8217;s net debt stood at $147 million at the end of 2023, while SAM had $298 million in cash and no financial debt. Zuanic said a cash offer for SAM would significantly increase Green Thumb&#8217;s leverage, making it an unlikely scenario. An <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38656307/big-players-in-u-s-cannabis-could-play-the-stock-value-card-in-m-a-new-report-shows">equity-based offer</a>, either 50/50 or 100%, would be more feasible and <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39214567/rumors-of-green-thumb-and-boston-beer-merger-what-investors-need-to-know-analyst-br">beneficial for both parties.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40427128/verano-green-thumb-marimeds-strong-q2-unpacking-the-cannabis-earnings-surge">Verano, Green Thumb &amp; MariMed&#8217;s Strong Q2: Unpacking The Cannabis Earnings Surge</a></li>
</ul>
<h3 class="wp-block-heading">GTBIF Price Action</h3>
Green Thumb's shares traded 0.10% higher at $10.34 per share after the market close on Wednesday afternoon.

Cannabis Giant Green Thumb Secures $150M Credit Facility, 'Strengthens Our Already Clean Balance Sheet'

United States Surgeon General Dr. Vivek Murthy released a new Surgeon General's Advisory on Alcohol and Cancer Risk, outlining the direct link betw...

Surgeon General issues new advisory on link between alcohol and cancer risk

The Surgeon General pushes for cancer warnings labels for alcoholic drinks

The Surgeon General pushes for cancer warning labels for alcoholic drinks

Boston Beer (SAM) is down -6.2%, or -$18.70 to $282.56. Published first on TheFly – the ultimate source for real-time, market-moving breaking finan...

Boston Beer falls -6.2%

Beer and spirits investors have a chance to fade the Surgeon General

Molson Coors ($TAP), and other alcohol stocks, have lost their fizz on news that the U.S. Surgeon General wants to place new labels on beer, wine, ...

Molson Coors (TAP) Stock Loses Fizz as U.S. Surgeon General Calls for New Warning Label on Alcohol

Trending stocks as Wall Street steps into first days of 2025 with cautiousness

Alcohol companies could face a challenge with younger consumers after Surgeon General warning

Radical Transparency (2024 Edition): +107% Total Portfolio Return

In a report released today, Nadine Sarwat from Bernstein maintained a Hold rating on Boston Beer (SAM – Research Report), with a price target of $3...

Bernstein Sticks to Its Hold Rating for Boston Beer (SAM)

AAPL

ABEV

ALTO

AMTX

BARK

BNED

BZFD

CABGY

CNVS

CRNC

CURI

CVNA

DAVE

DGEAF

DVCMY

DVDCF

EHTH

EVGO

FARM

GOOG

GOOGL

HEINY

KOPN

LCID

LICY

MESA

MGPI

MSFT

NGVC

NISTF

NMRA

NPSCY

NVDA

PDRDF

PLCE

PLUG

PRNDY

PTON

REVG

RGTI

RIVN

ROOT

RRGB

RYAM

RZLV

SMCI

SNDL

SOFI

SOUN

TSLA

VINE

VWESQ

Press Releases

Angry Orchard's New Hide & Shriek Prank Pack Swaps Hard Cider for Screams

Restaurants

SAMUEL ADAMS INVITES YOU TO HAVE A COLD SAM ADAMS...WITH A COLD SAM ADAMS

Sun Cruiser and YouGov Survey Says Nearly Two-Thirds of Americans Would Eliminate Daylight Saving Time if They Could; 40 Percent Admit They "Hate" Darker Days

Boston Beer Reports Third Quarter Financial Results

Dogfish Head Drops Limited-Edition "24 Days of Dogfish Head" Package

Twisted Tea Hard Iced Tea Releases 25 Days of Twistmas: A Holiday Countdown for Diehard Fans Looking to Unwrap the Fun, One Can at a Time

BOSTON BEER COMPANY LAUNCHES  EMERALD HOUR, A NEW LINE OF NON-ALCOHOLIC CANNABIS COCKTAILS

BOSTON BEER UPDATES 2024 FINANCIAL GUIDANCE TO REFLECT SUPPLIER CONTRACT AMENDMENT

Samuel Adams Offers Two Dry January Tips: Try Just The Haze IPA and  Don't Waste Great Beer

Lighten Up! Dogfish Head Flips the Script on New Year's Resolutions, Celebrates  New 30 Minute Light IPA on "Quitter's Day" with Beer Money & Other Rewards

Comments

Boston Beer Co

空売り

Boston Beer Co (NYSE:SAM) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル